Figure 1.
PRISMA flow diagram of papers selected.
Table 1.
Characteristics of included studies.
Table 2.
Source of data, method of death ascertainment or confirmation and quality assessment of the included studies.
Figure 2.
Forest plot of 16 studies reporting TB-CFR for HIV positive patients receiving ART (by Region).
Table 3.
Outcomes considered in the included studies.
Figure 3.
Forest plot studies reporting the relative risk of death during TB treatment by ART status.